Ticker brief
ZEAL
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
9
authors 14d
5
crowd 14d
-0.4σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-08 → 2026-10-14 · now +0.25 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @bioinvestor24 | A | -0.87 | 5 | -0.53 |
| @KontraInvest | A | +1.21 | 1 | +0.10 |
| @FierceBiotech | A | -0.83 | 1 | -0.35 |
| @BiopharmIQ | B | · | 1 | +0.00 |
| @OpenOutcrier | C | · | 1 | +0.25 |
Recent signals9of 9 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @OpenOutcrier | +0.25 | Generate Biomedicines and Zealand Pharma announced an AI drug partnership. | · | tweet ↗ |
| 2026-10-13 | @bioinvestor24 | -0.60 | Criticizes Zealand's peptide research and questions competition for its Roche amylin deal. | · | tweet ↗ |
| 2026-10-13 | @bioinvestor24 | -0.70 | Calls Roche's deal immaterial and Zealand's amylin asset weak. | · | tweet ↗ |
| 2026-10-11 | @bioinvestor24 | -0.45 | Uses diabetes data to favor GLP-1/GIP dual agonists from LLY and VKTX over glucagon-based approaches. | · | tweet ↗ |
| 2026-10-10 | @BiopharmIQ | +0.00 | Weekly biotech roundup summarizes mixed clinical, commercial, and pipeline developments. | · | tweet ↗ |
| 2026-10-08 | @bioinvestor24 | -0.50 | Says disappointing ZEAL and Novo Nordisk trials have weighed on the obesity sector. | · | tweet ↗ |
| 2026-10-08 | @bioinvestor24 | -0.40 | Assesses ZEAL weight loss as better than expected but A1C efficacy as modest amid weak obesity trials. | · | tweet ↗ |
| 2026-10-08 | @FierceBiotech | -0.35 | Blood-sugar data weakened enthusiasm for Zealand and Roche's amylin obesity drug. | · | tweet ↗ |
| 2026-10-08 | @KontraInvest | +0.10 | Zealand and Roche announce mixed Phase 2 obesity and diabetes trial results. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.